C96.4 — Sarcoma of dendritic cells (accessory cells)
Is C96.4 billable?
Yes — C96.4 is billable for FY2027. C96.4 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. C96.4 may be submitted for encounters from October 1, 2026 through September 30, 2027.
C96.4 at a glance
| Code | C96.4 |
|---|---|
| Description | Sarcoma of dendritic cells (accessory cells) |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does C96.4 group to?
C96.4 sits in MDC 17 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 820Lymphoma and Leukemia with Major O.R. Procedures with MCCsurgical
- 821Lymphoma and Leukemia with Major O.R. Procedures with CCsurgical
- 822Lymphoma and Leukemia with Major O.R. Procedures without CC/MCCsurgical
As a secondary diagnosis, C96.4 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.
How is C96.4 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to C96.4. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Sarcoma › dendritic cells (of)
- Sarcoma › follicular dendritic cell (of)
- Sarcoma › interdigitating dendritic cell (of)
- Sarcoma › Langerhans cell (of)
Inclusion terms
Alternative wording in documentation that is classified to C96.4.
- Follicular dendritic cell sarcoma
- Interdigitating dendritic cell sarcoma
- Langerhans cell sarcoma
Excludes1 — never code together — inherited from C96
The conditions below can never be reported together with C96.4 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79)
Excludes2 — not included here — inherited from C81-C96
The conditions below are not part of C96.4, but a patient may have both at the same time. When documentation supports it, C96.4 and the excluded code may both be reported.
How long has C96.4 existed?
C96.4 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.
What other codes are in the C96 family? (7)
- C96.0Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis
- C96.2Malignant mast cell neoplasmnot billable
- C96.5Multifocal and unisystemic Langerhans-cell histiocytosis
- C96.6Unifocal Langerhans-cell histiocytosis
- C96.AHistiocytic sarcoma
- C96.ZOther specified malignant neoplasms of lymphoid, hematopoietic and related tissue
- C96.9Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified